Company Profile

Starpharma Holdings Ltd (OTCQX: SPHRY)
3:14 PM UTC, 06/21/24
Last: $0.63 Change: -0.03 %Change: -4.58% Volume: 2,000
Detailed Quote
Open: $ 0.63   Volume: 2,000
High: $ 0.63   Yield(%) 0.00
Low: $ 0.63   P/E Ratio (ttm): n/a
Dividend ($): n/a   Market Cap ($): 25.55M
EPS ($) n/a   Shares Out: 41.20M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -6.77
% Price Change (last 13 weeks): -26.80
% Price Change (last 26 weeks): -47.68
% Price Change (last 52 weeks): -70.08
% Price Change (year to date): -46.55
Management Effectiveness
Return on Equity (%): -37.27
Return on Assets (%): -26.24
Return on Invested Capital (%): -35.21
Profitability
Gross Profit Margin (%): 41.60
Net Profit Margin (%): -532.09
Operating Profit Margin (%): -839.50
Price & Volume
50-day Moving Average: $0.76
200-day Moving Average: $n/a
Avg. Daily Vol. (last 50 days): 2,758
Avg. Daily Vol. (last 200 days): n/a
52-wk high: $2.81
52-wk low: $0.63
Bid: $n/a
Ask: $n/a
Company Information
Starpharma Holdings Ltd. engages in the research and development of dendrimer products for pharmaceutical, life science and other applications. The firm's programs include: VivaGel portfolio, Drug delivery and Agrochemicals, which develops a number of products internally and others via commercial partnerships. Its product VivaGel, a gel-based formulation of a proprietary dendrimer and is under clinical development for the treatment and prevention of bacterial vaginosis and also as a vaginal microbicide to prevent the transmission of sexually transmitted infections including HIV and genital herpes. The company was founded in 1996 and is headquartered in Abbotsford, Australia.
Starpharma Holdings Ltd
4-6 Southampton Crescent
Abbotsford VI 3067

Phone: 61.3.8532.2700
Fax: 61.3.9510.5955
http://www.starpharma.com
Per Share Data
Earnings (1year) ($): -0.14
Annual Dividend ($): 0.00
Current P/E Ratio (ttm): n/a
Book Value ($): 0.56
Cash Flow ($): -0.24
Valuation Ratios
Price/Earnings (x): n/a
Price/Sales (x): 42.71
Price/Book (x): 3.66
Price/Cash Flow (x): n/a
Financial Strength
Quick Ratio (x): 3.06
Current Ratio (x): 3.26
LT Debt/Equity (x): 7.90
Total Debt/Equity (x): 23.76



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.